Notificação de entrada na fase nacional - PCT
#1.3
06/09/2026
RPI 2892
Application data
Number
112025017570Type
Filing
Publication
PCT
US2024016495 Examination has not been requested yet. Without that request by 02/20/2027, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:02/20/2027(179 days left)
Latest action published by the INPI: 06/09/2026. We update with every new RPI gazette, published weekly.
Applicants
ASSEMBLY BIOSCIENCES, INC.
US
Inventors
J. Z. (pessoa física)
US
J. Y. (pessoa física)
US
M. W. (pessoa física)
US
M. Z. (pessoa física)
US
IPC Classification
Priority claims
US
63/446,976 · 02/20/2023
US
63/534,249 · 08/23/2023
Abstract
A presente divulgação fornece, em parte, compostos de benzotiazepina (dia)zepina e suas composições farmacêuticas e métodos de tratamento de infecções pelo vírus da hepatite B (HBV) e pelo vírus da hepatite D (HDV).
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
06/09/2026
RPI 2892
#1.1
09/09/2025
RPI 2853
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.